Bardur Sigurgeirsson
5PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 26, 2021
Secukinumab demonstrates efficacy, safety, and tolerability upon administration by 2 ml autoinjector in adult patients with plaque psoriasis: 52-week results from MATURE, a randomized, placebo-controlled trial.Bardur Sigurgeirsson, John Browning, Stephen Tyring
|Apr 26, 2021
Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study.Bardur Sigurgeirsson, Knut Schäkel, Chih-Ho Hong
|Feb 19, 2021
Loss-of-Function Variants in the Tumor-Suppressor Gene PTPN14 Confer Increased Cancer Risk.Thorhildur Olafsdottir, Simon N Stacey, Gardar Sveinbjornsson
|Oct 29, 2019
Comparison of pharmacokinetics, safety and tolerability of secukinumab administered subcutaneously using different delivery systems in healthy volunteers and in psoriasis patients.Gerard Bruin, Hans-Ulrich P Hockey, Phillip La Stella
|Nov 24, 2018
A survey among dermatologists: diagnostics of superficial fungal infections - what is used and what is needed to initiate therapy and assess efficacy?D M L Saunte, B M Piraccini, A Y Sergeev
Pageof 1
Frequent Collaborators
2 joint publications
Gerard Bruin
1 joint publications
Thorhildur Olafsdottir
1 joint publications
Kavita Y Sarin
1 joint publications
Rafn Benediktsson
1 joint publications
Solvi Rognvaldsson
1 joint publications
Valgerdur Steinthorsdottir
1 joint publications
Hannes P Eggertsson
1 joint publications
Bjarni V Halldorsson
1 joint publications
Thorunn Rafnar
1 joint publications
Chih-Ho Hong
